-+ 0.00%
-+ 0.00%
-+ 0.00%

Apyx Medical Q1 net loss narrows to $2.1 million; revenue rises 32.4% to $12.5 million

PUBT·05/07/2026 11:10:19
Listen to the news
Apyx Medical Q1 net loss narrows to $2.1 million; revenue rises 32.4% to $12.5 million
  • Apyx Medical posted Q1 revenue of $12.5 million, up 32.4%, as Surgical Aesthetics climbed 36.1% to $10.7 million.
  • Net loss attributable to stockholders narrowed to $2.1 million, or $0.05 per share.
  • Adjusted EBITDA loss improved to $326,000 from $2.4 million, while gross margin widened 3.4 percentage points to 63.5%.
  • International revenue rose 62.9% to $4.38 million, driven in part by Apyx One Console and single-use handpiece sales in South Korea following December 2025 regulatory approval.
  • FY2026 revenue outlook was raised to $59 million-$60 million, with Surgical Aesthetics seen at $54 million-$55 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apyx Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605070700PRIMZONEFULLFEED9715080) on May 07, 2026, and is solely responsible for the information contained therein.